Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Piacquadio, MD
Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Francisco Flores, Md
Miramar, Florida, United States
- Daniel M. Stewart, Do
Clinton Township, Michigan, United States
- Cyaandi Dove, Dpm
Las Vegas, Nevada, United States
- Robert S. Haber, Md
South Euclid, Ohio, United States
- Cynthia Strout, Md
Mt. Pleasant, South Carolina, United States
- Michael H. Gold, Md
Nashville, Tennessee, United States
- Jeffrey Adelglass, Md
Plano, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2011
- Primary completion
- 30 Apr 2012
- Completion
- 31 Aug 2012
- Last update posted
- 9 Jan 2013
- Registered enrollment
- 264
- Registry id
- NCT01353976
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.